Stemtech Corp
corporate_fare Company Profile
Stemtech Corp (OTC:STEK) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 5 items for STEK at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 9/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for STEK spans 10-Q, 10-K.
Recent high-impact activity:
- Stemtech Q2 Revenue Falls 9.8%, Shares Outstanding Surge 543% as Convertible Debt Converts
- Stemtech Q1 Revenue Drops 47% to $463K, Net Loss Narrows Despite Sales Decline
- Stemtech Reports Q1 Loss Amid 450% Share Dilution, Going Concern Warning, and Control Weaknesses
- Stemtech Revenue Plunges 43% to $2.88M in FY25 Amid Supply Issues
- Stemtech Corp Reports 43% Revenue Decline, Widening Losses, Going Concern Warning, and Massive Dilution
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 514,582 shares in STEK as of the September 15, 2026 settlement, a 349955.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 1, 2026, 91.1% of STEK volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for STEK, detected from its recent SEC filings · based on capital-structure filings through 2026-06-22.
Massive Share Dilution · Continued Going Concern Warning
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →